Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma
Zunpeng Yu, Manqing Du, Long Lu
Biomedicines (2022) Vol. 10, Iss. 2, pp. 317-317
Open Access | Times Cited: 17

Showing 17 citing articles:

Comprehensive Analyses of Ferroptosis-Related Alterations and Their Prognostic Significance in Glioblastoma
Yuan Tian, Hongtao Liu, Caiqing Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 19
A Rare Patient of SEZ6L2 Antibody–Associated Cerebellar Ataxia
Chenhui Cao, Wenli Li, Yao Zhang, et al.
The Cerebellum (2025) Vol. 24, Iss. 3
Closed Access
Identification of a Novel Eight-Gene Risk Model for Predicting Survival in Glioblastoma: A Comprehensive Bioinformatic Analysis
Huy-Hoang Dang, Hoang Dang Khoa Ta, Truc T.T. Nguyen, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3899-3899
Open Access | Times Cited: 7
Anti-SEZ6L2 antibodies in paraneoplastic cerebellar syndrome: case report and review of the literature
Annika Kather, Florian Holtbernd, Robert Brunkhorst, et al.
Neurological Research and Practice (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 12
Advancing Precision Prognostication in Neuro-Oncology: Machine Learning Models for Data-Driven Personalized Survival Predictions in IDH-Wildtype Glioblastoma
Mert Karabacak, Pemla Jagtiani, Long Di, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas
Irati Hervás-Corpión, Jorge Navarro-Calvo, Paula Martín-Climent, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 374-374
Open Access | Times Cited: 5
Autoimmune cerebellar ataxia
Hiroaki Yaguchi, Akihiko Kudo, Ichiro Yabe
Clinical and Experimental Neuroimmunology (2023) Vol. 14, Iss. 4, pp. 159-166
Closed Access | Times Cited: 5
CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors
Bin Zhang, Jianyi Zhao, Yongzhi Wang, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 6, pp. 917-927
Open Access | Times Cited: 5
Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model
Rayan Nassani, Yahya Bokhari, Bahauddeen M. Alrfaei
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0287448-e0287448
Open Access | Times Cited: 5
A molecular signature for the G6PC3/SLC37A2/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype
Sima Torabidastgerdooei, Marie‐Eve Roy, Borhane Annabi
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
The construction of a novel prognostic prediction model for glioma based on GWAS-identified prognostic-related risk loci
Jie Wei, Yujie Li, Wenqian Zhou, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
A Genomic Instability–Associated Prognostic Signature for Glioblastoma Patients
Xiaodong Chen, Fen Tian, Zeyu Wu
World Neurosurgery (2022) Vol. 167, pp. e515-e526
Closed Access | Times Cited: 6
Seven Fatty Acid Metabolism-Related Genes as Potential Biomarkers for Predicting the Prognosis and Immunotherapy Responses in Patients with Esophageal Cancer
Ya Guo, Shupei Pan, Yue Ke, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1721-1721
Open Access | Times Cited: 4
Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway
Pengren Luo, Jinhong Yang, Li-peng Jian, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access
Three Novel Neuroblastoma Biomarkers Revealed by Integrative Analysis of GEO data
Zijun Xiong, Mingjun Xu, Ping Yuan, et al.
Research Square (Research Square) (2024)
Open Access
AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma
Dengxia Fan, Moses Yang, Hye Jung Lee, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 1
Development of Prognostic Indicator Based on AU-Rich Elements-Related Genes in Glioblastoma
Xiaohong Chen, Ying Xu, Maode Wang, et al.
World Neurosurgery (2023) Vol. 175, pp. e601-e613
Closed Access
Page 1

Scroll to top